Cargando…
Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
Here, we demonstrate that electroporation-enhanced immunization with a rationally designed HPV DNA vaccine (GX-188E), preferentially targeting HPV antigens to dendritic cells, elicits a significant E6/E7-specific IFN-γ-producing T-cell response in all nine cervical intraepithelial neoplasia 3 (CIN3)...
Autores principales: | Kim, Tae Jin, Jin, Hyun-Tak, Hur, Soo-Young, Yang, Hyun Gul, Seo, Yong Bok, Hong, Sung Ran, Lee, Chang-Woo, Kim, Suhyeon, Woo, Jung-Won, Park, Ki Seok, Hwang, Youn-Young, Park, Jaehan, Lee, In-Ho, Lim, Kyung-Taek, Lee, Ki-Heon, Jeong, Mi Seon, Surh, Charles D., Suh, You Suk, Park, Jong Sup, Sung, Young Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220493/ https://www.ncbi.nlm.nih.gov/pubmed/25354725 http://dx.doi.org/10.1038/ncomms6317 |
Ejemplares similares
-
E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma
por: Choi, Youn-Jin, et al.
Publicado: (2018) -
Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology
por: Ki, Eun Young, et al.
Publicado: (2019) -
Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
por: Sung, Yeoun Eun, et al.
Publicado: (2016) -
Clinicopathological Implications of Human Papilloma Virus (HPV) L1 Capsid Protein Immunoreactivity in HPV16-Positive Cervical Cytology
por: Lee, Sung-Jong, et al.
Publicado: (2013) -
Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
por: So, Kyeong A, et al.
Publicado: (2018)